Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master TrialAmy Burd, John C. Byrd, Ross L. Levine et al.|Nature Medicine|2020Cited by 195
Entospletinib with decitabine in acute myeloid leukemia with mutant <i>TP53</i> or complex karyotype: A phase 2 substudy of the Beat AML Master TrialVu H. Duong, Michael Boyiadzis, Amy S. Ruppert et al.|Cancer|2023Cited by 32
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker StudyRobert Wesolowski, Bhuvaneswari Ramaswamy, Rachel M. Layman et al.|The Oncologist|2020Cited by 14